secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001372514-23-000160
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals furnishes updated investor presentation with no specific new facts disclosed
--------------------------------------------------------------------------------

- Filed under Item 7.01 and 9.01; presentation provided as Exhibit 99.1.
- No financial guidance, operational milestones, or clinical data disclosed in the filing.
- The presentation may be used for investor meetings; content not detailed in this 8-K.
- Ticker: KPRX; sentiment neutral due to lack of material new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/0001372514-23-000160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/kprx-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer